ARDS Meeting Notes
The ARDS provides participants with a Meeting Notes PDF which includes most slide presentations from the meeting. The Meeting Notes are taken and assembled by talented and rising retinal stars. They attend every talk and capture the essence of the vigorous post-talk discussion, for which the ARDS is deservedly famous.
Please email ards@medconfs.com to request a copy of the Meeting Notes. Be sure to include the year(s) requested.
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
| Past ARDS Speakers “The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.” David Parke, II |
|
|---|---|
| Records per page: | |
| 2021 49th Annual Meeting | |
| Allen C. Ho, MD, FACS | The Promise of Gene Therapy for Neovascular and Atrophic AMD |
| Timothy G. Murray, MD, MBA | Advanced Strategies for Evaluation and Treatment of Radiation Retinopathy |
| Timothy G. Murray, MD, MBA | Combined Posterior and Anterior Surgical Interventions |
| Timothy W. Olsen, MD | Macular Reconstruction |
| Timothy W. Olsen, MD | Reticular Pseudodrusen and Coronary Artery Disease |
| Ryan M. Rich, MD | Brolucizumab - One Year Later |
| Ryan M. Rich, MD | Early Experiences with Operative 3D Viewing Systems |
| Panel Discussion | New Approaches in the Management of Posterior Segment Infections/ Inflammations |
| Panel Discussion | Pharmacologic Therapy of Non-AMD Retinal Diseases: DME, PDR, RVO, CME, and VMT |
| Panel Discussion | Retinal Detachment from Primary To Complex |
| Panel Discussion | Surgical Care and Intravitreal Injections: What Are The Risks And How Can We Mitigate Risk For Our Patients |
| 2020 48th Annual Meeting | |
| RV Paul Chan, MD, MSc, MBA | Artificial Intelligence and Pediatric Retina |
| RV Paul Chan, MD, MSc, MBA | Pediatric Retinal Imaging |
| Jay S. Duker, MD | OCTA – What it is. What it is Good For. |
| Jay S. Duker, MD | Unusual Causes of Peripheral Retinal Elevations |
| Philip J. Ferrone, MD | Best Approaches for Pediatric RD |
| Philip J. Ferrone, MD | Pediatric Macular Holes |
| Glenn J. Jaffe, MD | Intraocular Drug Delivery - A Winding Journey |
| Glenn J. Jaffe, MD | Surgical Rounds |
| Baruch D. Kuppermann, MD, PhD | Diabetic Macular Edema in Cataract Surgery: The Role of Inflammation |
| Baruch D. Kuppermann, MD, PhD | The Role of Neuroprotection in Retinal Diseases |
| Carl D. Regillo, MD | Perfluorocarbon Liquids: Pearls and Pitfalls |
| Carl D. Regillo, MD | Second Generation Anti-VEGF Agents |
| Carol L. Shields, MD | Intraocular Tumors - A Footprint into the Future |
| Giovanni Staurenghi, MD | OCTA: Are the Platforms All the Same? |
| PREV | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | NEXT |
